NasdaqHealth CareSurgical & Medical Instruments & ApparatusEDEN PRAIRIE, MN

NeuroOne Medical Technologies Corporation NMTC

Ask your AI

Estimated market cap $6.78M9.11M shares, shares as of Aug 11, 2026CIK 1500198

Insider trades, 12 mo

2 buys · 6 sells

$54.9K sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

16.1% of shares · 2 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q2 2026

What changed in NeuroOne Medical Technologies Corporation's latest quarterly report, compared with the one before.

Filed Aug 13, 2026 · Quarter ended Jun 30, 2026

Compared with the 10-Q for the quarter ended Mar 31, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in NeuroOne Medical Technologies Corporation's latest quarterly report, compared with the one before.

Loading…

Insider trades

8 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Aug 27, 2026. Insiders have two business days to file.

Recent insider trades

David J. Wambeke Chief Business Officer	Aug 27 Form 4 ↗	Buy	+$67.0K 33,333 sh @ $2.01	-60.2%
Mark Christianson Market Development Director	Jun 30 Form 4 ↗	Sale	−$31.8K 10,000 sh @ $3.18	-76.5%
Mark Christianson Business Development Director	Mar 30 Form 4 ↗	Sale	−$11.4K 15,363 sh @ $0.74	-102.7%
Mark Christianson Business Development Director	Mar 13 Form 4 ↗	Sale	−$80 100 sh @ $0.80	-97.4%
Mark Christianson Business Development Director	Mar 12 Form 4 ↗	Sale	−$654 817 sh @ $0.80	-97.5%

All NMTC insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

1.46M shares

15 funds report NMTC. Values checked against market prices.

Funds own 24% of shares (Q2 2026)

25 funds hold the stock.

Q3 2026: 16% · 5,560 of ~8,900 funds reported so far

Q1 2026<0.1%
Q2 202624%
Q3 2026 (so far)16%

Q3 2026. 2 new, 2 added to, 5 trimmed, 12 exited since Q2 2026.

Top 13F holders
#
1	Bleichroeder LP 13F ↗	666,666	$686.7K	unchanged
2	Vanguard Capital Management LLC 13F ↗	352,150	$362.7K	-0.2%
3	Perkins Capital Management Inc 13F ↗	159,854	$164.7K	-34.7%
4	Geode Capital Management, LLC 13F ↗	93,555	$96.4K	unchanged
5	Vanguard Fiduciary Trust Co 13F ↗	49,018	$50.5K	unchanged
6	State Street Corp 13F ↗	43,015	$44.3K	New
7	Cambridge Investment Research Advisors, Inc. 13F ↗	28,715	$30.0K	-49.6%
8	BlackRock, Inc. 13F ↗	24,029	$24.8K	-4.3%
9	Barclays plc 13F ↗	18,757	$19.3K	+24580.3%
10	UBS Group AG 13F ↗	14,264	$14.7K	+443.8%

One of these funds reports its values in thousands of dollars; its figures are shown in dollars.

Download CSV Every fund that holds NMTC, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What NeuroOne Medical Technologies Corporation and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What NeuroOne Medical Technologies Corporation and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report, adjusted for splits

Funds holding the stock by quarter

Q1 2026	1	—	3	$16
Q2 2026	25	+24	2.07M	$6.3M
Q3 2026	15	-10	1.46M	$1.5M

Each point is a quarter-end, from Q1 2026 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (64130M308). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2026) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits (1-for-6 on Apr 16, 2026): reports from before a split are multiplied by its ratio, so every quarter is on the share count of Q3 2026.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes2 in 12 mo 8-K events2 in 90 days Patents3 patents granted Short interestFINRA · updated Oct 15 Planned insider salesForm 144 · 2 in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials1 active FDA decisionsLatest Aug 15 IPO history5 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: NEUROONE MEDICAL TECHNOLOGIES Corp
Address: 7599 ANAGRAM DR, EDEN PRAIRIE, MN 55344
Phone: (952) 426-1383
Fiscal year ends: Sep 30
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: DE
Listed as: NMTC (Nasdaq)
Former names: Original Source Entertainment, Inc. (until 2017)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$0.7451−$0.00 (−0.31%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.7451 · High $1.10Nov 13, 2026

Aug 13, 2026Low $0.7451 · High $2.18Nov 13, 2026

Nov 13, 2025Low $0.7451 · High $5.88Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. The stock split 1-for-6 on Apr 16, 2026; earlier prices are shown divided by the split ratio. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.